Four-year results of low-dose CT screening and nodule management in the ITALUNG trial

Journal of Thoracic Oncology

Volumn 8, Issue 7, 2013, Pages 866-875

  Pegna, Andrea Lopes ^a   Picozzi, Giulia ^b   Falaschi, Fabio ^c   Carrozzi, Laura ^c   Falchini, Massimo ^d   Carozzi, Francesca Maria ^b   Pistelli, Francesco ^c   Comin, Camilla ^e   Deliperi, Annalisa ^c   Grazzini, Michela ^f   Innocenti, Florio ^f   Maddau, Cristina ^b   Vella, Alessandra ^g   Vaggelli, Luca ^a   Paci, Eugenio ^b   Mascalchi, Mario ^d   Bianchi, R ^h   Ronchi, C ^h   Aquilini, F ^h   Cini, S ^h   De Santis, M ^h   Baliva, F ^h   Chella, A ^h   Tavanti, L ^h   Natali, I ^h   Bartolucci, M ^h   Crisci, E ^h   De Francisci, A ^h   Gabbrielli, S ^h   Roselli, G ^h   Masi, A ^h   Battola, L ^h   De Liperi, A L ^h   Spinelli, C ^h   Vannucchi, L ^h   Petruzzelli, A ^h   Gadda, D ^h   Neri, A T ^h   Niccolai, F ^h   Janni, A ^h   Mussi, A ^h   Lucchi, M ^h   Fontanini, G ^h   Tognetti, A R ^h   Cordopatri, G ^h   Giusti, F ^h   Esposito, I ^h   more..

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Center for the Study and Prevention of Oncology   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f Hospital of Pistoia   (Italy)

^g UNIVERSITY HOSPITAL OF SIENA   (Italy)

^h NONE

Author keywords

Cancer; Computed tomography; Nuclear medicine; Pulmonary biopsy

Indexed keywords

ANTIBIOTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CANCER GROWTH; COMPUTED TOMOGRAPHY SCANNER; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCREENING TEST; SMOKING;

EID: 84880924900     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31828f68d6     Document Type: Article

References (76)

1. American Cancer Society. Cancer Facts and Figures 2012. Atlanta, GA: American Cancer Society, 2012.
2. Travis WD. Pathology of lung cancer. Clin Chest Med 2012:32:669-692.
3. AIRTUM Working Group. Italian cancer figures, report 2009: cancer trend (1998-2005). Epidemiol Prev. 2009;33(XX Suppl 1):1-168.
4. Howlander N, Noone AM, Krapcho M, et al. (Eds.) SEER Cancer Statistics Review, 1975-2009. Bethesda, MD: National Cancer Institutehttp://seer. cancer.gov/csr/1975-2009-pops09/. Accessed April 2012.
5. AIRTUM Working Group. Italian cancer figures, report 2011: survival of cancer patients in Italy. Epidemiol Prev. 2011;35:1-200.
6. Midthun DE, Jett JR, Ross ME. Overview of the risk factors, pathology, and clinical manifestations of lung cancer. 2012. Available at: http://www. uptodate.com. Accessed on
7. Kubík AK, Parkin DM, Zatloukal P. Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer 2000;89(11 Suppl):2363-2368.
8. Parkin DM, Moss SM. Lung cancer screening: improved survival but no reduction in deaths-the role of "overdiagnosis." Cancer 2000;89(11 Suppl):2369-2376.
9. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006;98:748-756.
10. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality. The Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306:1865-1873.
11. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
12. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418-2429.
13. International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-1771.
14. Patz EF Jr, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000;343:1627-1633.
15. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA 2007;297:953-961.
16. Paci E. Observational, one-arm studies and randomized population-based trials for evaluation of the efficacy of lung cancer screening. J Thorac Oncol 2007;2(5 Suppl):S45-S46.
17. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P; Writing Committee, Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: The Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-121.
18. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-315.
19. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-874.
20. Lopes Pegna A, Picozzi G, Mascalchi M, et al.; ITALUNG Study Research Group. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:34-40.
21. Infante M, Lutman FR, Cavuto S, et al.; DANTE Study Group. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 2008;59:355-363.
22. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. J Thorac Oncol 2009;4:608-614.
23. Croswell JM, Baker SG, Marcus PM, Clapp JD, Kramer BS. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med 2010;152:505-12, W176.
24. Becker N, Motsch E, Gross ML, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 2012;138:1475-1486.
25. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 2011;66:308-313.
26. National Lung Screening Trial Research Team. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010;102(23):1771-1779
27. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
28. Sox HC. Better evidence about screening for lung cancer. N Engl J Med 2011;365:455-457. Accessed December 28, 2012.
29. Wood DE. Maximizing the benefit and minimizing the risks of lung cancer screening. J Thorac Imaging 2012;27:211-212.
30. Zompatori M, Mascalchi M, Ciccarese F, Sverzellati N, Pastorino U. Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art. Radiol Med 2013;118:51-61.
31. American Lung Association. Providing guidance on lung cancer screening to patients and physicians April 23, 2012. Available at: http://www. lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/Accessed April 23, 2012.
32. NCCN Clinical Practice Guidelines in Oncology. Lung cancer screening. Version 1.2013. Available at: http://www.nccn.org Accessed June 15, 2012.
33. Infante M, Cavuto S, Lutman FR, et al.; DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009;180:445-453.
34. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296-301.
35. Henschke CI. International Early Lung Cancer Action Program: enrolment and screening protocol. Available at: http://www.IELCAP.org. Accessed March 17, 2004.
36. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177-184.
37. Ashraf H, Dirksen A, Loft A, et al. Combined use of positron emission tomography and volume doubling time in lung cancer screening with lowdose CT scanning. Thorax 2011;66:315-319.
38. Gohagan JK, Marcus PM, Fagerstrom RM, et al.; Lung Screening Study Research Group. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005;47:9-15.
39. Field JK, Smith RA, Duffy SW, et al. The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group. J Thorac Oncol 2006;1:497-498.
40. Carozzi FM, Bisanzi S, Falini P, et al.; ITALUNG Study Research Group. Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: perspectives of integrated strategies for early diagnosis. Lung Cancer 2010;68:216-221.
41. Wormanns D, Ludwig K, Beyer F, Heindel W, Diederich S. Detection of pulmonary nodules at multirow-detector CT: effectiveness of double reading to improve sensitivity at standard-dose and low-dose chest CT. Eur Radiol 2005;15:14-22.
42. Bastarrika G, García-Velloso MJ, Lozano MD, et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005;171:1378-1383.
43. Lindell RM, Hartman TE, Swensen SJ, et al. Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population. AJR Am J Roentgenol 2005;185:126-131.
44. Vazquez MF, Flieder DB. Small peripheral glandular lesions detected by screening CT for lung cancer. A diagnostic dilemma for the pathologist. Radiol Clin North Am 2000;38:579-589.
45. Vazquez MF, Koizumi JH, Henschke CI, Yankelevitz DF. Reliability of cytologic diagnosis of early lung cancer. Cancer 2007;111:252-258.
46. Picozzi G, Diciotti S, Falchini M, et al. Operator-dependent reproducibility of size measurements of small phantoms and lung nodules examined with low-dose thin-section computed tomography. Invest Radiol 2006;41:831-839.
47. Libby DM, Smith JP, Altorki NK, Pasmantier MW, Yankelevitz D, Henschke CI. Managing the small pulmonary nodule discovered by CT. Chest 2004;125:1522-1529.
48. Travis WD, Brambilla E Müller-Hermelink HK, Harris CC (Eds). World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of the lung, pleura, thymus and heart. Lyon, France: IARC Press, 2004.
49. Mascalchi M, Mazzoni LN, Falchini M, et al. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT. Br J Radiol 2012;85:1134-1139.
50. Giordano L, Giorgi D, Ventura L, Castagno R, Paci E, Segnan N. Time trends of process and impact indicators in Italian breast screening programmes (1999-2009). Epidemiol Prev 2011;35(5-6 Suppl 5):28-38.
51. Sali L, Grazzini G, Ventura L, et al. Computed tomography colonography in subjects with positive faecal occult blood test refusing optical colonoscopy. Digest Liver Dis December 19, 2012 [Epub ahead of print].
52. Blanchon T, Bréchot JM, Grenier PA, et al.; Dépiscan Group. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007;58:50-58.
53. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-2229.
54. MacRedmond R, McVey G, Lee M, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax 2006;61:54-56.
55. Patz EF Jr, Swensen SJ, Herndon JE 2nd. Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations. J Clin Oncol 2004;22:2202-2206.
56. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259-265.
57. Das M, Mühlenbruch G, Mahnken AH, et al. Asbestos Surveillance Program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestos-exposed high-risk individuals using low-dose multidetector- row CT. Eur Radiol 2007;17:1193-1199.
58. Carrozzi L, Viegi G. Lung cancer and chronic obstructive pulmonary disease: the story goes on. Radiology 2011;261:688-691.
59. Sozzi G, Pastorino U, Croce CM. MicroRNAs and lung cancer: from markers to targets. Cell Cycle 2011;10:2045-2046.
60. Boeri M, Verri C, Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 2011;108:3713-3718.
61. Early warnings. Screening programmes for cancer detection are not always as effective at saving lives as might be hoped. Improving the situation will require a concerted effort on a broad front (Editorial). Nature 2009;458:679.
62. Wilson DO, Weissfeld JL, Fuhrman CR, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008;178:956-961.
63. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508-513.
64. Diederich S, Wormanns D, Semik M, et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002;222:773-781.
65. Kido S, Kuriyama K, Higashiyama M, Kasugai T, Kuroda C. Fractal analysis of small peripheral pulmonary nodules in thin-section CT: evaluation of the lung-nodule interfaces. J Comput Assist Tomogr 2002;26:573-578.
66. Wang H, Guo XH, Jia ZW, et al. Multilevel binomial logistic prediction model for malignant pulmonary nodules based on texture features of CT image. Eur J Radiol 2010;74:124-129.
67. Veronesi G, Bellomi M, Mulshine JL, et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008;61:340-349.
68. Veronesi G, Bellomi M, Veronesi U, et al. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann Thorac Surg 2007;84:959-65; discussion 965.
69. Veronesi G, Bellomi M, Scanagatta P, et al. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg 2008;136:611-617.
70. Libby DM, Wu N, Lee IJ, et al. CT screening for lung cancer: the value of short-term CT follow-up. Chest 2006;129:1039-1042.
71. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362:593-597.
72. Wagnetz U, Menezes RJ, Boerner S, et al. CT screening for lung cancer: implication of lung biopsy recommendations. AJR Am J Roentgenol 2012;198:351-358.
73. Fassina A, Corradin M, Zardo D, Cappellesso R, Corbetti F, Fassan M. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules. Cytopathology 2011;22:306-312.
74. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC; American College of Chest Physicians. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence- based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):94S-107S.
75. Travis WD, Brambilla E, Noguchi M, et al. American Thoracic Society. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc 2011;8:381-385.
76. Pastorino U. Lung cancer screening. Br J Cancer 2010;102:1681-1686.